Pathological examination of factors involved in PD-L1 expression in patients with oral tongue squamous cell carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Pathological examination of factors involved in PD-L1 expression in patients with oral tongue squamous cell carcinoma ; volume:46 ; number:1 ; day:8 ; month:8 ; year:2024 ; pages:1-7 ; date:12.2024
Maxillofacial plastic and reconstructive surgery ; 46, Heft 1 (8.8.2024), 1-7, 12.2024
- Urheber
-
Koyama, Yu
Ogawa, Chiharu
Kurihara, Chihiro
Hashimoto, Nao
Shinagawa, Shota
Okazaki, Hiroya
Koyama, Takumi
Sugahara, Keisuke
Katakura, Akira
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40902-024-00441-w
- URN
-
urn:nbn:de:101:1-2410272128099.606361086077
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koyama, Yu
- Ogawa, Chiharu
- Kurihara, Chihiro
- Hashimoto, Nao
- Shinagawa, Shota
- Okazaki, Hiroya
- Koyama, Takumi
- Sugahara, Keisuke
- Katakura, Akira
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinoma
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma
Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma
Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinoma
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma
Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma
Automated PD-L1 Scoring Using Artificial Intelligence in Head and Neck Squamous Cell Carcinoma
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation
PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma
Evaluation of PD-L1 Expression and HPV Genotyping in Anal Squamous Cell Carcinoma
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
Characterisation of tumour-immune phenotypes and PD-L1 positivity in squamous bladder cancer
Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinoma
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
PD-L1 immunohistochemistry assay optimization to provide more comprehensive pathological information in classic Hodgkin lymphoma
Automated PD-L1 scoring using artificial intelligence in head and neck squamous cell carcinoma